醫思健康(02138.HK):預計中期純利同比減少不多於50%
格隆匯11月11日丨醫思健康(02138.HK)公佈,董事會基於目前可得的初步未經審計的集團截至2022年9月30日止的六個月(簡稱"報吿期內")的綜合管理帳目所作出最新評估,預計集團錄得財務記錄如下:
(i)報吿期內除税後溢利("純利")較截至2021年9月30日同期的約1.961億港元純利減少不多於50%;及
(ii)報吿期內扣除利息、税項、自有物業折舊、廠房及設備攤銷前的盈利("息税折舊及攤銷前之盈利")較截至2021年9月30日的期間相應的約3.234億港元息税折舊及攤銷前的盈利,減少不多於20%。
董事會認為,報吿期內純利和息税折舊及攤銷前之盈利下降的主要原因是:(i)對入境旅客實施的旅遊限制和衞生檢疫安排的延長削弱了我們的收入;(ii)集團之美容及養生業務強制停業,香港業務停業20天、澳門業務平均停業31天,以及廣州、深圳和上海的業務分別平均停業10天、26天及122天;及(iii)集團雖投放了資本開支以支持新醫療設施內生增長,但相關設施於報吿期內暫未投入服務及產生相應收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.